Stem definition | Drug id | CAS RN |
---|---|---|
retinol derivatives | 2831 | 68-26-8 |
Dose | Unit | Route |
---|---|---|
50 | TU | O |
50 | TU | P |
800 | U | N |
Property | Value | Reference |
---|---|---|
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 2 | Benet LZ, Broccatelli F, Oprea TI |
S (Water solubility) | 0.04 mg/mL | Benet LZ, Broccatelli F, Oprea TI |
EoM (Fraction excreted unchanged in urine) | 0 % | Benet LZ, Broccatelli F, Oprea TI |
Date | Agency | Company | Orphan |
---|---|---|---|
Feb. 20, 1953 | FDA | HOSPIRA |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Pneumonia aspiration | 237.00 | 15.14 | 112 | 8431 | 30892 | 50565689 |
Coma | 168.43 | 15.14 | 110 | 8433 | 56769 | 50539812 |
Gastrooesophageal reflux disease | 158.95 | 15.14 | 119 | 8424 | 76309 | 50520272 |
Blood magnesium increased | 123.85 | 15.14 | 37 | 8506 | 2843 | 50593738 |
Pleural thickening | 123.18 | 15.14 | 36 | 8507 | 2563 | 50594018 |
Somnolence | 118.38 | 15.14 | 138 | 8405 | 154847 | 50441734 |
Presbyacusis | 116.50 | 15.14 | 35 | 8508 | 2741 | 50593840 |
Pleural fibrosis | 113.81 | 15.14 | 36 | 8507 | 3348 | 50593233 |
Deafness neurosensory | 107.60 | 15.14 | 37 | 8506 | 4464 | 50592117 |
Epigastric discomfort | 94.40 | 15.14 | 36 | 8507 | 5834 | 50590747 |
Cyst | 74.95 | 15.14 | 38 | 8505 | 12149 | 50584432 |
Osteopenia | 63.07 | 15.14 | 38 | 8505 | 16980 | 50579601 |
Blood potassium increased | 61.77 | 15.14 | 37 | 8506 | 16361 | 50580220 |
Skin lesion | 56.29 | 15.14 | 42 | 8501 | 26685 | 50569896 |
Dry eye | 51.57 | 15.14 | 43 | 8500 | 32052 | 50564529 |
Bone cyst | 42.08 | 15.14 | 15 | 8528 | 2009 | 50594572 |
Choanal stenosis | 35.90 | 15.14 | 6 | 8537 | 27 | 50596554 |
Blood creatinine increased | 35.02 | 15.14 | 53 | 8490 | 76107 | 50520474 |
Osteosclerosis | 34.25 | 15.14 | 15 | 8528 | 3452 | 50593129 |
Enterobacter infection | 31.87 | 15.14 | 12 | 8531 | 1876 | 50594705 |
Infective pulmonary exacerbation of cystic fibrosis | 30.18 | 15.14 | 18 | 8525 | 7891 | 50588690 |
Granulomatous liver disease | 29.59 | 15.14 | 9 | 8534 | 734 | 50595847 |
Osteoarthritis | 27.72 | 15.14 | 45 | 8498 | 68561 | 50528020 |
Aorta hypoplasia | 27.04 | 15.14 | 6 | 8537 | 139 | 50596442 |
Exostosis | 26.07 | 15.14 | 19 | 8524 | 11634 | 50584947 |
Underdose | 24.26 | 15.14 | 23 | 8520 | 20255 | 50576326 |
Gastrointestinal disorder | 23.16 | 15.14 | 50 | 8493 | 94406 | 50502175 |
Osteochondritis | 22.97 | 15.14 | 4 | 8539 | 24 | 50596557 |
Deformity | 22.58 | 15.14 | 15 | 8528 | 7925 | 50588656 |
Renal impairment | 22.02 | 15.14 | 43 | 8500 | 75618 | 50520963 |
Sleep disorder | 19.73 | 15.14 | 35 | 8508 | 57248 | 50539333 |
Tracheo-oesophageal fistula | 19.28 | 15.14 | 6 | 8537 | 528 | 50596053 |
Malabsorption | 18.35 | 15.14 | 10 | 8533 | 3696 | 50592885 |
Bone hypertrophy | 16.96 | 15.14 | 5 | 8538 | 366 | 50596215 |
Hiatus hernia strangulated | 15.71 | 15.14 | 4 | 8539 | 169 | 50596412 |
Anomaly of external ear congenital | 15.71 | 15.14 | 4 | 8539 | 169 | 50596412 |
Treatment failure | 15.69 | 15.14 | 55 | 8488 | 137582 | 50458999 |
Hepatic cirrhosis | 15.65 | 15.14 | 17 | 8526 | 17560 | 50579021 |
Oesophageal atresia | 15.24 | 15.14 | 5 | 8538 | 522 | 50596059 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Infective pulmonary exacerbation of cystic fibrosis | 55.79 | 17.34 | 22 | 3121 | 6214 | 29565170 |
Coronavirus infection | 17.41 | 17.34 | 8 | 3135 | 3280 | 29568104 |
Febrile convulsion | 17.35 | 17.34 | 5 | 3138 | 540 | 29570844 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Pneumonia aspiration | 185.16 | 13.75 | 113 | 9432 | 59158 | 64430029 |
Gastrooesophageal reflux disease | 168.52 | 13.75 | 121 | 9424 | 83022 | 64406165 |
Coma | 147.33 | 13.75 | 114 | 9431 | 87501 | 64401686 |
Somnolence | 121.63 | 13.75 | 150 | 9395 | 203495 | 64285692 |
Presbyacusis | 105.79 | 13.75 | 31 | 9514 | 2544 | 64486643 |
Pleural thickening | 104.23 | 13.75 | 31 | 9514 | 2679 | 64486508 |
Blood magnesium increased | 98.85 | 13.75 | 31 | 9514 | 3200 | 64485987 |
Pleural fibrosis | 91.97 | 13.75 | 31 | 9514 | 4019 | 64485168 |
Deafness neurosensory | 88.88 | 13.75 | 34 | 9511 | 6340 | 64482847 |
Epigastric discomfort | 79.71 | 13.75 | 32 | 9513 | 6779 | 64482408 |
Infective pulmonary exacerbation of cystic fibrosis | 74.76 | 13.75 | 36 | 9509 | 11760 | 64477427 |
Cyst | 62.28 | 13.75 | 32 | 9513 | 11995 | 64477192 |
Dry eye | 60.44 | 13.75 | 43 | 9502 | 28976 | 64460211 |
Osteopenia | 57.25 | 13.75 | 33 | 9512 | 15507 | 64473680 |
Skin lesion | 47.59 | 13.75 | 41 | 9504 | 36441 | 64452746 |
Bone cyst | 42.81 | 13.75 | 15 | 9530 | 2182 | 64487005 |
Blood potassium increased | 37.59 | 13.75 | 31 | 9514 | 25949 | 64463238 |
Osteosclerosis | 32.74 | 13.75 | 14 | 9531 | 3472 | 64485715 |
Deformity | 27.62 | 13.75 | 15 | 9530 | 6282 | 64482905 |
Osteoarthritis | 24.61 | 13.75 | 38 | 9507 | 63298 | 64425889 |
Osteochondritis | 23.50 | 13.75 | 4 | 9541 | 24 | 64489163 |
Sleep disorder | 23.44 | 13.75 | 36 | 9509 | 59673 | 64429514 |
Cystic fibrosis | 23.34 | 13.75 | 11 | 9534 | 3423 | 64485764 |
Enterobacter infection | 22.57 | 13.75 | 11 | 9534 | 3685 | 64485502 |
Granulomatous liver disease | 22.50 | 13.75 | 8 | 9537 | 1214 | 64487973 |
Underdose | 22.12 | 13.75 | 23 | 9522 | 25806 | 64463381 |
Exostosis | 21.64 | 13.75 | 16 | 9529 | 11422 | 64477765 |
Gastrointestinal disorder | 20.86 | 13.75 | 43 | 9502 | 89666 | 64399521 |
Treatment failure | 20.45 | 13.75 | 50 | 9495 | 116766 | 64372421 |
Completed suicide | 18.79 | 13.75 | 5 | 9540 | 224409 | 64264778 |
Bone hypertrophy | 18.25 | 13.75 | 5 | 9540 | 321 | 64488866 |
Vitamin A decreased | 18.08 | 13.75 | 3 | 9542 | 15 | 64489172 |
Prealbumin decreased | 17.37 | 13.75 | 4 | 9541 | 126 | 64489061 |
Breast cancer | 16.57 | 13.75 | 21 | 9524 | 29127 | 64460060 |
Hypervitaminosis A | 16.45 | 13.75 | 3 | 9542 | 28 | 64489159 |
Hiatus hernia strangulated | 16.23 | 13.75 | 4 | 9541 | 169 | 64489018 |
Blood creatinine increased | 15.72 | 13.75 | 50 | 9495 | 135732 | 64353455 |
Oesophageal adenocarcinoma | 14.03 | 13.75 | 5 | 9540 | 764 | 64488423 |
Hospitalisation | 14.02 | 13.75 | 33 | 9512 | 75174 | 64414013 |
None
Source | Code | Description |
---|---|---|
ATC | A11CA01 | ALIMENTARY TRACT AND METABOLISM VITAMINS VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO Vitamin A, plain |
ATC | D10AD02 | DERMATOLOGICALS ANTI-ACNE PREPARATIONS ANTI-ACNE PREPARATIONS FOR TOPICAL USE Retinoids for topical use in acne |
ATC | R01AX02 | RESPIRATORY SYSTEM NASAL PREPARATIONS DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE Other nasal preparations |
ATC | S01XA02 | SENSORY ORGANS OPHTHALMOLOGICALS OTHER OPHTHALMOLOGICALS Other ophthalmologicals |
FDA CS | M0022788 | Vitamin A |
CHEBI has role | CHEBI:24020 | fat-soluble vitamins |
CHEBI has role | CHEBI:25212 | metabolites |
MeSH PA | D018977 | Micronutrients |
MeSH PA | D014815 | Vitamins |
FDA EPC | N0000175950 | Vitamin A |
CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
CHEBI has role | CHEBI:76924 | plant metabolites |
CHEBI has role | CHEBI:77746 | Homo sapiens metabolite |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Vitamin A deficiency | indication | 72000004 | |
Vitamin deficiency | indication | 85670002 | |
Mineral deficiency | indication | 111379007 | |
Prevention of dental caries | indication | 426482000 | |
Mineral Deficiency Prevention | indication | ||
Vitamin Deficiency Prevention | indication | ||
Diaper rash | off-label use | 91487003 | |
Abetalipoproteinemia | off-label use | 190787008 | DOID:1386 |
Skin irritation | off-label use | 367466007 | |
Peptic ulcer | contraindication | 13200003 | DOID:750 |
Primary hyperoxaluria | contraindication | 17901006 | DOID:2977 |
Hyperphosphatemia | contraindication | 20165001 | DOID:0050459 |
Gastroenteritis | contraindication | 25374005 | DOID:2326 |
Hypervitaminosis D | contraindication | 27712000 | DOID:9971 |
Sarcoidosis | contraindication | 31541009 | DOID:11335 |
Hemosiderosis | contraindication | 39011001 | DOID:12119 |
Hemolytic anemia | contraindication | 61261009 | DOID:583 |
Hypervitaminosis A | contraindication | 64559002 | DOID:9972 |
Ulcerative colitis | contraindication | 64766004 | DOID:8577 |
Hypercalcemia | contraindication | 66931009 | DOID:12678 |
Kidney disease | contraindication | 90708001 | DOID:557 |
Kidney stone | contraindication | 95570007 | |
Anemia due to enzyme deficiency | contraindication | 111577008 | |
Hb SS disease | contraindication | 127040003 | DOID:10923 |
Disease of liver | contraindication | 235856003 | DOID:409 |
Pregnancy, function | contraindication | 289908002 | |
Arteriosclerosis obliterans | contraindication | 361133006 | DOID:5160 |
Diverticular disease | contraindication | 397881000 | |
Hemochromatosis | contraindication | 399187006 | DOID:2352 |
Repeated Blood Transfusions | contraindication | ||
Malabsorption States | contraindication |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 13.62 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
11-cis retinol dehydrogenase | Enzyme | WOMBAT-PK | |||||||
Retinol dehydrogenase 12 | Enzyme | WOMBAT-PK | |||||||
Retinol dehydrogenase 13 | Enzyme | WOMBAT-PK | |||||||
Retinol-binding protein 3 | Surface antigen | WOMBAT-PK | |||||||
Retinol-binding protein 5 | Cytosolic other | WOMBAT-PK | |||||||
Retinoid-binding protein 7 | Cytosolic other | WOMBAT-PK | |||||||
Retinol-binding protein 4 | Secreted | Kd | 6.74 | CHEMBL | |||||
Retinol-binding protein 2 | Cytosolic other | WOMBAT-PK | |||||||
Retinal dehydrogenase 2 | Enzyme | WOMBAT-PK | |||||||
Retinal dehydrogenase 1 | Enzyme | WOMBAT-PK | |||||||
Retinaldehyde-binding protein 1 | Transporter | WOMBAT-PK | |||||||
Retinol-binding protein 1 | Cytosolic other | WOMBAT-PK | |||||||
Amyloid beta A4 protein | Unclassified | IC50 | 6.75 | CHEMBL | |||||
Nuclear receptor subfamily 2 group C member 2 | Nuclear other | AGONIST | EC50 | 4.71 | IUPHAR | ||||
Alpha-synuclein | Transporter | IC50 | 6.72 | CHEMBL | |||||
Beta-lactoglobulin | Unclassified | Kd | 7.44 | CHEMBL |
ID | Source |
---|---|
4021164 | VUID |
N0000148615 | NUI |
D06543 | KEGG_DRUG |
11103-57-4 | SECONDARY_CAS_RN |
4017648 | VANDF |
4021164 | VANDF |
4021715 | VANDF |
C0042839 | UMLSCUI |
CHEBI:50211 | CHEBI |
RTL | PDB_CHEM_ID |
CHEMBL986 | ChEMBL_ID |
CHEMBL1675 | ChEMBL_ID |
DB00162 | DRUGBANK_ID |
D014801 | MESH_DESCRIPTOR_UI |
445354 | PUBCHEM_CID |
4053 | IUPHAR_LIGAND_ID |
2243 | INN_ID |
G2SH0XKK91 | UNII |
11246 | RXNORM |
232172 | MMSL |
5678 | MMSL |
975 | MMSL |
d00402 | MMSL |
001000 | NDDF |
82156005 | SNOMEDCT_US |
82622003 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
VitafolOne | HUMAN PRESCRIPTION DRUG LABEL | 16 | 0642-0070 | CAPSULE, GELATIN COATED | 330 ug | ORAL | unapproved drug other | 14 sections |
Vitafol Caplet | HUMAN PRESCRIPTION DRUG LABEL | 12 | 0642-0072 | CAPSULE | 6000 [iU] | ORAL | UNAPPROVED DRUG OTHER | 13 sections |
Vitafol OB Caplet | HUMAN PRESCRIPTION DRUG LABEL | 15 | 0642-0079 | TABLET | 2700 [iU] | ORAL | Unapproved drug other | 14 sections |
Vitafol Plus | HUMAN PRESCRIPTION DRUG LABEL | 17 | 0642-0092 | CAPSULE, LIQUID FILLED | 1100 [iU] | ORAL | UNAPPROVED DRUG OTHER | 13 sections |
Strovite Forte Caplet | HUMAN PRESCRIPTION DRUG LABEL | 19 | 0642-0204 | TABLET, COATED | 4000 [iU] | ORAL | UNAPPROVED DRUG OTHER | 15 sections |
Strovite One Caplets | HUMAN PRESCRIPTION DRUG LABEL | 20 | 0642-0207 | TABLET | 900 ug | ORAL | UNAPPROVED DRUG OTHER | 14 sections |
Reaphirm Plant Source DHA | HUMAN PRESCRIPTION DRUG LABEL | 16 | 0642-3010 | CAPSULE, GELATIN COATED | 1100 [iU] | ORAL | unapproved drug other | 7 sections |
O-Cal Prenatal Vitamin | HUMAN PRESCRIPTION DRUG LABEL | 16 | 0813-0202 | TABLET | 2500 [iU] | ORAL | UNAPPROVED DRUG OTHER | 6 sections |
Budpak Vitamin A and D | HUMAN OTC DRUG LABEL | 2 | 27293-036 | CREAM | 181.80 [iU] | TOPICAL | OTC monograph not final | 11 sections |
Multivitamin with fluoride | HUMAN PRESCRIPTION DRUG LABEL | 11 | 50090-0356 | TABLET, CHEWABLE | 2500 [iU] | ORAL | UNAPPROVED DRUG OTHER | 8 sections |
Multivitamin with fluoride | HUMAN PRESCRIPTION DRUG LABEL | 11 | 50090-0435 | TABLET, CHEWABLE | 2500 [iU] | ORAL | UNAPPROVED DRUG OTHER | 8 sections |
Multivitamin with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 12 | 50090-4475 | TABLET, CHEWABLE | 750 ug | ORAL | unapproved drug other | 10 sections |
Multi Vitamin and Mineralvitamin | HUMAN OTC DRUG LABEL | 11 | 51220-2001 | TABLET, CHEWABLE | 3.50 mg | ORAL | unapproved drug other | 8 sections |
Vitamin A and D | HUMAN OTC DRUG LABEL | 2 | 52000-026 | CREAM | 181.80 [iU] | TOPICAL | OTC monograph not final | 11 sections |
Kimchi Vitaminchewable multivitamin | HUMAN OTC DRUG LABEL | 11 | 52102-1001 | TABLET, CHEWABLE | 0.68 mg | ORAL | unapproved drug other | 2 sections |
Multi-Vitamin Fluoride Drops | HUMAN PRESCRIPTION DRUG LABEL | 10 | 52959-593 | SOLUTION | 1500 [iU] | ORAL | Unapproved drug other | 11 sections |
Multivitamin with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 11 | 58657-163 | TABLET, CHEWABLE | 2500 [iU] | ORAL | unapproved drug other | 10 sections |
Multivitamin with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 11 | 58657-164 | TABLET, CHEWABLE | 2500 [iU] | ORAL | unapproved drug other | 10 sections |
Multivitamin with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 11 | 58657-165 | TABLET, CHEWABLE | 2500 [iU] | ORAL | unapproved drug other | 10 sections |
M-Natal Plus | HUMAN PRESCRIPTION DRUG LABEL | 14 | 58657-170 | TABLET | 4000 [iU] | ORAL | unapproved drug other | 7 sections |
Tri-Vite Drops with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 4 | 58657-323 | SOLUTION | 1500 [iU] | ORAL | unapproved drug other | 9 sections |
Tri-Vite Drops with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 4 | 58657-324 | SOLUTION | 1500 [iU] | ORAL | unapproved drug other | 9 sections |
Multivitamin with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 12 | 59088-107 | TABLET, CHEWABLE | 2500 [iU] | ORAL | unapproved drug other | 10 sections |
Multivitamin with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 12 | 59088-108 | TABLET, CHEWABLE | 2500 [iU] | ORAL | unapproved drug other | 9 sections |
Multivitamin with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 12 | 59088-109 | TABLET, CHEWABLE | 750 ug | ORAL | unapproved drug other | 10 sections |
INATAL ADVANCE | HUMAN PRESCRIPTION DRUG LABEL | 16 | 63044-153 | TABLET, COATED | 2700 [iU] | ORAL | Unapproved drug other | 11 sections |
INATAL Ultra | HUMAN PRESCRIPTION DRUG LABEL | 16 | 63044-154 | TABLET, COATED | 2700 [iU] | ORAL | Unapproved drug other | 10 sections |
Multivitamin with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 11 | 63629-1134 | TABLET, CHEWABLE | 2500 [iU] | ORAL | unapproved drug other | 10 sections |
Multivitamin with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 11 | 63629-1134 | TABLET, CHEWABLE | 2500 [iU] | ORAL | unapproved drug other | 10 sections |
Multivitamin with Fluoride | HUMAN PRESCRIPTION DRUG LABEL | 11 | 63629-1135 | TABLET, CHEWABLE | 2500 [iU] | ORAL | unapproved drug other | 10 sections |